Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the clinical study information.SummaryDifference0.1%

- Check16 days agoChange Detected- Revision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange Detected- Added Revision: v3.5.0 to the Study Documents. - Removed Revision: v3.4.3.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous v3.4.2. This is a minor update to the page metadata and does not impact the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedThe only visible change is the revision tag updating from v3.4.1 to v3.4.2, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check89 days agoChange DetectedA new site revision (v3.4.1) was added and the previous revision (v3.4.0) was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.